We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+22.39%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$808M
AUM Growth
+$28.1M
Cap. Flow
-$73M
Cap. Flow %
-9.03%
Top 10 Hldgs %
19.87%
Holding
167
New
45
Increased
29
Reduced
50
Closed
37

Top Buys

Rank Stock Value
1
LSCC icon
Lattice Semiconductor
LSCC
+$13.2M
2
AZTA icon
Azenta
AZTA
+$11.7M
3
ASAN icon
Asana
ASAN
+$11.1M
4
FATE icon
Fate Therapeutics
FATE
+$9.15M
5
RVLV icon
Revolve Group
RVLV
+$8.52M

Top Sells

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$15M
2
ALGT icon
Allegiant Air
ALGT
+$11.9M
3
HALO icon
Halozyme
HALO
+$11M
4
OSK icon
Oshkosh
OSK
+$10.4M
5
PCRX icon
Pacira BioSciences
PCRX
+$10.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.65%
2 Technology 26.22%
3 Industrials 16.12%
4 Consumer Discretionary 15.73%
5 Materials 2.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FIVN icon
101
FIVE9
FIVN
$2.28B
$2.95M 0.37%
16,110
-210
-1% -$36.2K
FOUR icon
102
Shift4
FOUR
$4.41B
$2.86M 0.35%
+30,470
New +$2.88M
WAL icon
103
Western Alliance Bancorporation
WAL
$9.2B
$2.84M 0.35%
30,545
– –
ENTG icon
104
Entegris
ENTG
$22B
$2.77M 0.34%
22,530
-15,575
-41% -$1.79M
SIMO icon
105
Silicon Motion
SIMO
$9.1B
$2.74M 0.34%
+42,710
New +$2.81M
HZNP
106
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.68M 0.33%
28,645
-19,755
-41% -$1.82M
CRL icon
107
Charles River Laboratories
CRL
$11.3B
$2.63M 0.33%
7,120
-10,890
-60% -$3.64M
OCUL icon
108
Ocular Therapeutix
OCUL
$1.89B
$2.55M 0.32%
179,700
-15,100
-8% -$230K
SGI
109
Somnigroup International
SGI
$14.7B
$2.3M 0.28%
+58,655
New +$2.25M
MKSI icon
110
MKS Inc
MKSI
$21.7B
$2.25M 0.28%
+12,660
New +$2.3M
WOOF icon
111
Petco
WOOF
$845M
$2.09M 0.26%
93,115
-118,130
-56% -$2.76M
FFIN icon
112
First Financial Bankshares
FFIN
$5.09B
$1.97M 0.24%
40,090
-185,675
-82% -$9.12M
FIVE icon
113
Five Below
FIVE
$12.3B
$1.96M 0.24%
10,155
-6,580
-39% -$1.26M
CAKE icon
114
Cheesecake Factory
CAKE
$5.26B
$1.94M 0.24%
35,855
-119,975
-77% -$6.94M
LFUS icon
115
Littelfuse
LFUS
$11.8B
$1.93M 0.24%
7,560
-7,200
-49% -$1.88M
CGNX icon
116
Cognex
CGNX
$11.9B
$1.91M 0.24%
22,665
– –
SNV
117
DELISTED
Synovus
SNV
$1.86M 0.23%
42,502
-141,993
-77% -$6.67M
DT icon
118
Dynatrace
DT
$13.3B
$1.86M 0.23%
+31,845
New +$1.66M
HYFM icon
119
Hydrofarm Holdings
HYFM
$9.15M
$1.83M 0.23%
+3,091
New +$1.82M
EEFT icon
120
Euronet Worldwide
EEFT
$2.93B
$1.77M 0.22%
13,115
-10,725
-45% -$1.56M
ALGT icon
121
Allegiant Air
ALGT
$2.82B
$1.69M 0.21%
8,725
-53,298
-86% -$11.9M
LZ icon
122
LegalZoom.com
LZ
$1.44B
$1.69M 0.21%
+44,635
New +$1.69M
MPWR icon
123
Monolithic Power Systems
MPWR
$65.6B
$1.58M 0.2%
4,235
– –
MIDD icon
124
Middleby
MIDD
$6.27B
$1.51M 0.19%
+8,740
New +$1.49M
TKNO icon
125
Alpha Teknova
TKNO
$296M
$1.47M 0.18%
+61,765
New +$1.56M
3 4
5
6 7

Similar funds

GF
Gray Foundation Cohoes, New York $397M AUM 32.69% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
STT
Singapore Technologies Telemedia Singapore $396M AUM 59.06% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
CF
Cypress Funds Los Angeles, California $398M AUM 8.77% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return

Lisanti Capital Growth's Q2 2021 Portfolio in Review

As of Q2 2021, Lisanti Capital Growth held 167 positions worth $808M, up 3.6% from $779M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Lisanti Capital Growth withdrew a net $73M in Q2 2021, closing 37 positions and reducing 50 holdings. Its most notable exit was Inspire Medical Systems, an estimated $15M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.

Against the trend, Lisanti Capital Growth opened a new position in Lattice Semiconductor worth $14.5M.

  • Lisanti Capital Growth's largest Q2 2021 buy was Lattice Semiconductor: 258,275 shares worth $14.5M.
  • Lisanti Capital Growth added most to Fate Therapeutics in Q2 2021, an estimated $9.15M increase.
  • Lisanti Capital Growth's biggest Q2 2021 reduction was Allegiant Air, cutting an estimated $11.9M.
  • Lisanti Capital Growth fully exited Inspire Medical Systems in Q2 2021, selling an estimated $15M.
  • Lisanti Capital Growth's ten largest holdings make up 20% of its $808M portfolio in Q2 2021.
  • Lisanti Capital Growth opened 45 new positions and closed 37 in Q2 2021.
  • Lisanti Capital Growth's portfolio value rose 3.6% quarter-over-quarter to $808M.

Based on Lisanti Capital Growth's 13F filing for Q2 2021, filed 16 Aug 2021.